ARUIX Mutual Fund

ARUIX Mutual Fund

NAV$15.22
See how much of ARUIX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
-
Expense Ratio
0.65%
Dividend Yield (Current)
3.83%
Holdings
46
Inception Date
Aug 31, 2023
Fund Family
ARGA Investment Management, LP
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+23.08%
1 Year+37.86%

Asset Allocation

Stocks: 100.00%
See how much of ARUIX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ELVElevance Health Inc4.56%
BMRNBiomarin Pharmaceutical Inc.4.41%
MHKMohawk Industries Inc.3.93%
TROWT Rowe Price Grp3.72%
CRMSalesforce Inc Crm Us Equity3.45%
Top 10 Concentration: 35.44%Report Date: Jun 30, 2026
Download all 46 holdings for ARUIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.83%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ARUIX Mutual Fund Overview

ARUIX Mutual Fund (ARGA Value Fund Institutional Class) is managed by ARGA Investment Management, LP. ARUIX expense ratio is 0.65%, holding 46 positions across sectors including Financials, Materials, Information Technology. Inception date: 2023-08-31.

ARUIX performance shows a YTD return of 23.08%. The 1-year return is 37.86%. ARUIX dividend yield stands at 3.83%, paid annually.

ARUIX top holdings include Elevance Health Inc (4.6%), Biomarin Pharmaceutical Inc. (4.4%), Mohawk Industries Inc. (3.9%), T Rowe Price Grp (3.7%), Salesforce Inc Crm Us Equity (3.5%). Go to all ARUIX holdings, ARUIX sectors, or ARUIX dividends.

ARUIX can be compared against other funds. Use ARUIX overlap to find shared positions, or ARUIX vs another fund for a side-by-side view. ARUIX alternatives are available via the screener, along with tax-loss harvesting opportunities.